grey market retatrutide isn't supposed to be everywhere. Touted as the next generation in the GLP-1 craze, it's an experimental weight-loss drug that is not authorized outside of clinical trials. The Food and Drug Retatrutide and the Grey Market:

2020 doi: 10.1210/clinem/dgz175

The secondary patents that extend effective market exclusivity are concentrated in two developmental windows: the formulation and manufacturing process work done during Phase I, and the indication and dosing discoveries that emerge from Phase II and III

With the help of CU Anschutz Innovations, the research team launched a startup to further advance these new therapies and will soon find if their fundamental discovery works

While Wegovy is the only Semaglutide product specifically approved by the FDA for weight loss (Novo), its counterparts, Ozempic and Rybelsus, are only approved for managing diabetes (FDA U.S

Frequent, severe, or unexplained episodes should be reviewed by a doctor, as medication doses may need adjustment